Free Notice to Take Deposition - District Court of Delaware - Delaware


File Size: 104.0 kB
Pages: 4
Date: December 31, 1969
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 670 Words, 4,479 Characters
Page Size: 613 x 792 pts
URL

https://www.findforms.com/pdf_files/ded/34913/88.pdf

Download Notice to Take Deposition - District Court of Delaware ( 104.0 kB)


Preview Notice to Take Deposition - District Court of Delaware
Case 1 :05-cv-00349—Gl\/IS Document 88 Filed 08/31/2006 Page 1 of 4 `
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
TALECRIS BIOTHERAPEUTICS, INC., and )
BAYER HEALTHCARE LLC, )
)
Plaintiffs, )
)
v. ) C.A. No. 05-649-GMS
)
BAXTER INTERNATIONAL INC., and ) Jug. Trial Demanded
BAXTER HEALTHCARE CORPORATION, )
)
Defendants. )
l
BAXTER HEALTHCARE CORPORATION, )
)
Counterclaimant, )
)
v. )
)
TALECRIS BIOTHERAPEUTICS, INC., and )
BAYER HEALTHCARE LLC, )‘
)
A Counterdefendants. )
E )
PLAINTIFFS’ THIRD NOTICE OF DEPOSITION TO BAXTER INTERNATIONAL
` INC. AND BAXTER HEALTHCARE CORPORATION
I PURSIEANT TO FED.R.CIV.P. 30gb)g6[
TO ALL PARTIES AND THEIR COUNSEL OF RECORD:
PLEASE TAKE NOTICE that, pursuant to Rule 30(‘o)(6) ofthe Federal Rules of Civil
Procedure, beginning on October 4, 2006 at 9:30 am., at the Hyatt Westlake Plaza in Thousand
Oaks, 880 S. Westlake Blvd., West Lake Village, California, 91361, counsel for Plaintiffs
Talecris Biotlierapeutics, Inc. and Bayer Healthcare LLC will take the deposition upon oral
examination of Defendant Baxter International Inc. by and through one or more of its officers,
directors, or managing agents, or other persons who are designated and consent to testify on its
l


Case 1:05-cv-00349—G|\/IS Document 88 Filed 08/31/2006 Page 2 of 4
behalf, with respect to the matters described in Schedule A hereto. The person or persons so
designated shall testify as to matters known or reasonably available to Defendant.
The deposition will be taken before an officer authorized to administer oaths and will
continue from hour to hour and day to day until completed. You are invited to attend and cross-
examine. Please be advised that this deposition may be recorded by videotape in addition to
stenographic recording, which will include the use of LiveNote real time transcription.
Aug¤Sr3i,2006 _........ -- r
Bradford J. Badke leffr B. Bove (#998)
Gabrielle Ciuffreda Mary W. Bourke (#2356)
ROPES & GRAY LLP Mark E. Freeman (#4257)
1251 Avenue of the Americas Jaclyn M. Mason (#4737)
New York, NY 10020-1105 L CONNOLLY BOVE LODGE & HUTZ LLP
(212) 596-9000 The Nemours Building
Y 1007 North Orange Street
, Attorneys for Bayer Wilmington, DE 1980l
Healthcare LLC (302) 658—9l41
, t Attorneys for Talecris Biotherapeutics, [nc.
and Bayer Healthcare LLC


Case 1:05-cv-00349—G|\/IS Document 88 Filed 08/31/2006 Page 3 of 4
EXHIBIT A I
DEFINITIONS
Except as otherwise provided herein, Plaintiffs hereby incorporate by reference all
definitions and instructions set forth in P1aintiffs’ First Set of Requests for Documents and
Things and Plaintiffs’ First Set of interrogatories (Nos. i·»~8) as though fully set forth herein.
1. "1l`DA" means the United States Food and Drug Administration, any of its subdivision
agencies, including the Center for Biologics Evaluation and Research, and any foreign regulatory
entity charged with government regulatory authority over immune globulin, plasrna—derived
products, or biological products or intended or used for human or animal administration.
DEPOSITION CATEGORIES
l. Clinical trials, specifically including all results and adverse events, performed on any
liquid IGIV product, including, but not limited to, 5% liquid formulations, 10% liquid
formulations, and GAMMAGARD Liquid, irrespective of past, present or future approval of the
product by the FDA or any equivalent foreign regulatory agency.
2. Detailed protocols for clinical trials performed using any liquid IGIV, irrespective of
past, present or future approval of the product by the FDA or any equivalent foreign regulatory
i agency.
l

Case 1:05-cv-00349—G|\/IS Document 88 Filed 08/31/2006 Page 4 of 4
CERTIFICATE OF SERVICE
I, JEFFREY B. BOVE, ESQUIRE, do hereby certify that I caused at true copy of the
foregoing document PLAIN'I`IFFS’ SECOND NOTICE OF DEPOSITION TO BAXTER
INTERNATIONAL INC. PURSUANT TO FED.R.CIV.P. 30gb)(6), to be served upon the
below listed in the manner indicated on August 31, 2006.
Via Hand Delivery and E—l\/[ai}
Philip A. Rovner, Esquire
Potter Anderson & Corroon LLP
Hercules Plaza
P. O. Box 951
Wilmington, DE 19899
(302) 984-6140
Via Federal Exgress and E-Mail
Susan Speeth, Esquire
Townsend and Townsend and Crew LLP
379 Lytton Avenue
Palo Alto, CA 9430l-1431
(435) 576-0200 /
Br » sf.
Je ( ·’ Squire (# 998)
¤i83965_1.DOC